SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-10-032270
Filing Date
2010-06-03
Accepted
2010-06-03 17:01:47
Documents
10
Effectiveness Date
2010-06-03

Document Format Files

Seq Description Document Type Size
1 DEFA14A a10-9595_23defa14a.htm DEFA14A 55384
2 GRAPHIC g959523bci001.gif GRAPHIC 51018
3 GRAPHIC g959523bci002.gif GRAPHIC 68406
4 GRAPHIC g959523bci003.gif GRAPHIC 113687
5 GRAPHIC g959523bci004.gif GRAPHIC 135647
6 GRAPHIC g959523bci005.gif GRAPHIC 115592
7 GRAPHIC g959523bci006.gif GRAPHIC 84806
8 GRAPHIC g959523bci007.gif GRAPHIC 90867
9 GRAPHIC g959523bci008.gif GRAPHIC 117070
10 GRAPHIC g959523bci009.gif GRAPHIC 67228
  Complete submission text file 0001104659-10-032270.txt   1221404
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-14680 | Film No.: 10876546
SIC: 2836 Biological Products, (No Diagnostic Substances)